⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 23, 2021World Journal of Clinical CasesOpen Access

Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease

José María Huguet Xavier Cortés Marta Maia Boscá-Watts M. Aguas Nuria Maroto Lidia Martí Cirilo Amorós José María Rubio Paredes

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

CT-P13 is an effective and safe infliximab biosimilar for the treatment of IBD in real-life practice and may be a valid and attractive alternative for the treatment of IBD.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Huguet et al. (2021) studied this question.

synapsesocial.com/papers/69dac69f387cf70698687aea https://doi.org/10.12998/wjcc.v9.i36.11285

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Quality of life in inflammatory bowel diseases: it is not all about the bowelOriginal Research · 2020 · 45 citations
2Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in BrazilCross-Sectional Study · 2019 · 93 citations
3Inflammatory Bowel DiseaseReview · 2002 · 3,183 citations
4Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic reviewSystematic Review · 2018 · 32 citations
5Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolutionReview · 2007 · 331 citations
6Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs diseaseCohort Study · 2009 · 671 citations
7Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-AnalysisRCT · 2011 · 606 citations
8Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCORisk Assessment · 2015 · 110 citations
9From contaminant to catastrophe: Applying integrated antimicrobial stewardship DIA model in a caseWorld Journal of Clinical Cases · 2026
10Beyond survival: Pain as the main determinant of long-term quality of life after thoracic trauma surgeryWorld Journal of Clinical Cases · 2026

More from World Journal of Clinical Cases

More from Hospital Universitari i Politècnic La Fe

More from Hospital Clínico Universitario de Valencia

More from Hospital General Universitario De Valencia

More from Hospital Universitario Doctor Peset

More from Hospital Arnau de Vilanova

More from Hospital de Sagunto

More from Hospital Comarcal de Inca